(2)The Commission is to lay down rules for the implementation of Regulation (EU) 2021/2282 as regards the cooperation, in the form of exchange of information, of the Coordination Group and the Commission acting as secretariat of the Coordination Group (‘the HTA secretariat’) with the European Medicines Agency and with the expert panels designated in accordance with Article 106(1) of Regulation (EU) 2017/745 of the European Parliament and of the Councilnote relevant for the joint work referred to in Articles 7 to 21 of Regulation (EU) 2021/2282. Pursuant to Article 30 of Regulation (EU) 2022/123 of the European Parliament and of the Councilnote, the European Medicines Agency is acting as secretariat for those expert panels. Therefore, the cooperation with the expert panels provided for in this Implementing Regulation should be conducted via the European Medicines Agency.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.